(2019)
Antibiotic treatment drives the diversification of the human gut resistome.
Genom Proteom Bioinf 17(1),
39-51.

Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Medizinische & Umweltmetagenomik: Mensch, Maus, Pflanzen, marine Lebewesen
- Systembiologie: Integration von –omics-Daten; Molekül/ Protein & Protein/ Protein Netzwerke
- Synthetische Biologie: Metabolische Modellierung auf Genomausmaß, Design von Probiotika, Entdeckung von Postbiotika
Publikationen
(2019)
Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial.
Sci Rep 9(1),
4736.
(2019)
Mining, analyzing, and integrating viral signals from metagenomic data.
Microbiome 7(1),
42.
(2018)
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis.
Ann Hematol 98(4),
869-879.
(2018)
Complete genome sequence of Escherichia coli strain WG5.
Genome Announc 6(2),
e01403-17.
(2018)
The environmental exposures and inner- and intercity traffic flows of the metro system may contribute to the human skin microbiome and resistome.
Cell Reports 24(5),
1190-1202.
(2018)
Differential microbial communities of omnivorous and herbivorous cattle in Southern China.
Comput Struct Biotechnol J 16,
54-60.
(2017)
Toward a Metagenomic Understanding on the Bacterial Composition and Resistome in Hong Kong Banknotes.
Front Microbiol 8,
632.
(2017)
NutriChem 2.0: exploring the effect of plant-based foods on human health and drug efficacy.
Database (2017),
(2017)
A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in ApcMin/+ mice.
J Appl Microbiol 122(3),
770-784.